These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 231031)

  • 1. [Recent notions concerning the treatments used in multiple sclerosis (author's transl)].
    Gonsette RE
    J Belge Med Phys Rehabil; 1978; 1(3):213-6. PubMed ID: 231031
    [No Abstract]   [Full Text] [Related]  

  • 2. New treatments for multiple sclerosis.
    Hallpike JF
    Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
    [No Abstract]   [Full Text] [Related]  

  • 3. [Selected methods of current treatment of multiple sclerosis].
    Orłowska E
    Neurol Neurochir Pol; 1980; 14(3):321-5. PubMed ID: 6158011
    [No Abstract]   [Full Text] [Related]  

  • 4. Medications used in the treatment of multiple sclerosis.
    Schapiro RT
    Phys Med Rehabil Clin N Am; 1999 May; 10(2):437-46, ix. PubMed ID: 10370939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of patients with multiple sclerosis with transfer factor (author's transl)].
    Romano EL; Pulido M; Layrisse Z; Malavé I
    Acta Cient Venez; 1978; 29(1):49-52. PubMed ID: 757718
    [No Abstract]   [Full Text] [Related]  

  • 6. [Present possibilities in the therapy of multiple sclerosis].
    Jedlicka P
    Cesk Neurol Neurochir; 1987 Jul; 50(4):209-17. PubMed ID: 2822262
    [No Abstract]   [Full Text] [Related]  

  • 7. [Review of the therapy of multiple sclerosis].
    De Rosa A; Puccini A; De Martino V
    Recenti Prog Med; 1982 Dec; 73(6):651-68. PubMed ID: 6308734
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiple sclerosis: pilot therapeutic trial of immunosuppressants.
    Cendrowski WS
    Schweiz Arch Neurol Neurochir Psychiatr; 1969; 105(2):241-6. PubMed ID: 4314087
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U; Majeron M; Mascetti A
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb; 96(1):163-84. PubMed ID: 4337775
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospects for the treatment of multiple sclerosis.
    Hughes RA
    J R Soc Med; 1991 Feb; 84(2):63-5. PubMed ID: 1847975
    [No Abstract]   [Full Text] [Related]  

  • 11. [ACTH treatment of multiple sclerosis].
    Boman K; Hokkanen E; Jarho L; Kivalo E
    Duodecim; 1966; 82(18):867-73. PubMed ID: 4288673
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of multiple sclerosis].
    Kesselring J
    Schweiz Med Wochenschr; 1984 Sep; 114(35):1186-90. PubMed ID: 6091263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation and review of ACTH (corticotrophin) in the treatment of acute exacerbations of multiple sclerosis.
    Blustein H; Wasserman RR; Halperin L; Garvin JS
    Med Times; 1969 Dec; 97(12):137-41. PubMed ID: 4312534
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppressive treatment of multiple sclerosis.
    Hadaway LC
    NITA; 1985; 8(6):503-5. PubMed ID: 2999647
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment and prevention of myelin disorders: multiple sclerosis.
    Abramsky O
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():489-92. PubMed ID: 6326915
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immunity in multiple sclerosis. Implications for pathogenesis and treatment.
    Thompson RF; Davenport J
    Mo Med; 1984 Oct; 81(10):669-73. PubMed ID: 6092887
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological aspects of multiple sclerosis].
    Bakouche P
    Munch Med Wochenschr; 1969 Sep; 111(39):1985-7. PubMed ID: 4309930
    [No Abstract]   [Full Text] [Related]  

  • 18. [Critical opinions on the treatment of multiple sclerosis with immunosuppressive agents].
    Skłodowski P
    Neurol Neurochir Pol; 1993; 27(6):877-83. PubMed ID: 8164783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive treatment in neurological disorders].
    Aarli JA
    Tidsskr Nor Laegeforen; 1973 Jun; 93(18):1395-7. PubMed ID: 4356438
    [No Abstract]   [Full Text] [Related]  

  • 20. [Attempt at treating multiple sclerosis with delayed-action corticotropin].
    Cendrowski W
    Neurol Neurochir Pol; 1972; 6(3):381-6. PubMed ID: 4338088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.